Back to Search
MICHAEL SCHWARZSCHILD, MD PHD
MD PHD
Neurology Physician
NPI: 1821088337IndividualAccepts Medicare
Education
HARVARD MEDICAL SCHOOL
Class of 1990
Research & Publications (20)
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
PMID 18413464·Arch Neurol·2008
4-observational
Adenosine A2A antagonists as neurotherapeutics: crossing the bridge.
PMID 17997007·Prog Neurobiol·2007
7-preclinical
Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease.
PMID 14663012·Neurology·2003
6-review
Caffeinated clues and the promise of adenosine A(2A) antagonists in PD.
PMID 11971080·Neurology·2002
6-review
Plasma urate and progression of mild cognitive impairment.
PMID 19066433·Neurodegener Dis·2009
8-other
Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's disease.
PMID 19110205·Neurotherapeutics·2009
6-review
Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality.
PMID 19131566·Am J Epidemiol·2009
8-other
Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.
PMID 19424986·Mov Disord·2009
8-other
Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease.
PMID 19525899·J Neuropathol Exp Neurol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15 PARKMAN ST, WANG 835
BOSTON, MA 02114 - Phone
- (617) 726-5532
Quick Facts
- NPI
- 1821088337
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile